Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Clinicopathological Significance of CaMKIIgamma Activation in AML

NCT00899743 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00899743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00899743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Clinicopathological Significance of CaMKIIgamma Activation in AML
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
June 30, 2009
Enrollment
132 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia